|
|
Volumn 764, Issue 1-2, 2001, Pages 327-347
|
|
Separation methods for nucleoside analogues used for treatment of HIV-1 infection
|
|
Author keywords
Nucleoside reverse transcriptase inhibitors; Reviews
|
|
Indexed keywords
ABSORPTION;
BIOASSAY;
DRUG THERAPY;
ENZYME INHIBITION;
HEALTH CARE;
MASS SPECTROMETRY;
METABOLITES;
PATIENT TREATMENT;
PHARMACOKINETICS;
TOXICITY;
ULTRAVIOLET RADIATION;
VIRUSES;
ANTIRETROVIRAL CONCENTRATIONS;
BIOMEDICAL ENGINEERING;
ABACAVIR;
AMPRENAVIR;
ANTIRETROVIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
NUCLEOSIDE DERIVATIVE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
ACCURACY;
ANALYTIC METHOD;
DRUG BLOOD LEVEL;
DRUG STRUCTURE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FLUORESCENCE POLARIZATION IMMUNOASSAY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIGHT ABSORPTION;
LIQUID LIQUID EXTRACTION;
MEDICAL CARE;
NONHUMAN;
PRIORITY JOURNAL;
RADIOIMMUNOASSAY;
REVIEW;
SOLID PHASE EXTRACTION;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
ANTI-HIV AGENTS;
HIV INFECTIONS;
HUMANS;
NUCLEOSIDES;
REVERSE TRANSCRIPTASE INHIBITORS;
|
|
EID: 0035950821
PISSN: 13872273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(01)00347-4 Document Type: Review |
|
Times cited : (20)
|
|
References (48)
|
